Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
Sales | 1,118 | 999 | 684 | 0 | 0 |
Cost of Goods | 967 | 754 | 453 | N/A | N/A |
Gross Profit | 151 | 245 | 231 | N/A | N/A |
Operating Expenses | 32,066 | 8,379 | 19,440 | 15,295 | 12,930 |
Operating Income | -30,948 | -7,380 | -18,756 | -15,295 | -12,930 |
Other Income | 719 | -17,384 | 564 | 457 | 371 |
Pre-tax Income | -30,229 | -24,764 | -18,192 | -14,838 | -12,559 |
Net Income Continuous | -30,229 | -22,934 | -18,192 | -14,838 | -12,559 |
Net Income | $-30,229 | $-22,934 | $-18,192 | $-14,838 | $-12,559 |
EPS Basic Total Ops | -0.98 | -0.77 | -0.63 | -0.56 | -0.48 |
EPS Basic Continuous Ops | -0.98 | -0.77 | -0.63 | -0.56 | -0.48 |
EPS Diluted Total Ops | -0.98 | -0.77 | -0.63 | -0.56 | -0.48 |
EPS Diluted Continuous Ops | -0.98 | -0.77 | -0.63 | -0.56 | -0.48 |
EBITDA(a) | $-30,726 | $-7,199 | $-18,640 | $-15,240 | $-12,880 |